USA-based subsidiary Vividion Therapeutics has taken over full development and commercialization rights for VVD-214, a ...

The European Commission has granted market authorization for Japanese ophthalmic drugmaker Santen Pharmaceutical’s (TYO: 4536 ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to women taking popular medicines ...

Japanese drugmaker Shionogi and US pharma major Eli Lilly were among the big spenders in pharma M&A during May.

Italian drug discovery specialist Axxam and German AI firm Molecular Health have struck a strategic alliance aimed at ...

US clinical-stage biotech Vigil Neuroscience (Nasdaq: VIGL) today announced a disappointing update on the Phase II IGNITE ...

US biotech BioAge Labs (Nasdaq: BIOA) is expanding its obesity pipeline just months after shelving its lead drug in the ...

Neuropsychiatric disorders specialist Alto Neuroscience, has entered into an asset purchase agreement with Chase Therapeutics ...

US clinical-stage biotech Sagimet Biosciences (Nasdaq: SGMT) today reported denifanstat met all primary and secondary ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

US pharma major Eli Lilly (NYSE: LLY) has struck a deal worth up to $870 million with Swedish biotech Camurus (Nasdaq ...

Danish dermatology specialist LEO Pharma has appointed Helle Hedegaard Juhl as executive vice president for global people and ...